| Trial ID: | L0788 |
| Source ID: | NCT02128074
|
| Associated Drug: |
Krx-0502
|
| Title: |
A Pilot Study of KRX-0502 (Ferric Citrate, Administered Without Food, in Treating Iron-deficiency Anemia
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT02128074/results
|
| Conditions: |
Anemia of Chronic Kidney Disease
|
| Interventions: |
DRUG: KRX-0502
|
| Outcome Measures: |
Primary: Change in Hemoglobin From Baseline to the End of 8-week Treatment Period, 8 weeks |
|
| Sponsor/Collaborators: |
Sponsor: Keryx Biopharmaceuticals
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
32
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2014-04
|
| Completion Date: |
2014-11
|
| Results First Posted: |
2018-08-24
|
| Last Update Posted: |
2018-08-24
|
| Locations: |
Barzilai Medical Center, Ashkelon, Israel|Western Galilee Hospital, Nahariya, Israel|Nazareth Hospital- EMMS, Nazareth, Israel
|
| URL: |
https://clinicaltrials.gov/show/NCT02128074
|
